2225.HK Overview

Company Profile

Jinhai Medical Technology Limited, an investment holding company, provides minimally invasive surgery solutions, medical products, and related services in the People's Republic of China and Singapore. It also offers manpower outsourcing and ancillary services to building and construction contractors. In addition, the company provides IT services; construction ancillary services, such as warehousing, cleaning, and building maintenance services; and dormitory services. Further, it offers engineering design and consultancy services; sells graphene material products; and accommodation for foreign worker's dormitory service. The company was formerly known as Jinhai International Group Holdings Limited and changed its name to Jinhai Medical Technology Limited in December 2023. The company was founded in 2006 and is headquartered in Wan Chai, Hong Kong. Jinhai Medical Technology Limited operates as a subsidiary of Full Fortune International Co., Ltd.

Related stocks

0656.HK

0656.HK • Hong Kong SAR China

4.77 HKD

4.94B USD 1Y -11.8%

0392.HK

0392.HK • Hong Kong SAR China

29.68 HKD

4.76B USD 1Y -8.7%

1196.HK

1196.HK • Hong Kong SAR China

REALORD TEC-NEW

3.6 HKD

2.65B USD 1Y +17.2%

0363.HK

0363.HK • Hong Kong SAR China

13.18 HKD

1.83B USD 1Y -3.1%

8088.T

8088.T • Japan

IWATANI CORPORATION

1,945.5 JPY

2.83B USD 1Y +16.7%

8020.T

8020.T • Japan

2,248 JPY

2.36B USD 1Y +43%

CARBORUNIV.NS

CARBORUNIV.NS • India

CARBORUNDUM UNIVERSAL LTD

1,202.6 INR

2.37B USD 1Y +31.6%

600704.SS

600704.SS • China

WUCHAN ZHONGDA GROUP CO.LTD

5 CNY

3.87B USD 1Y -18.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

5 Metrics

Country

Hong Kong SAR China

Region

Sector

Industry

Website

https://www.jin-hai.com.hk

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

77.9% p.a.

Max Drawdown (5Y)

-78.3%

Sharpe Ratio (5Y)

0.54

Beta Factor

0.41

Size Class

Large Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

Unprofitable business model: The company is currently generating net losses.

Strong cyclicality: The business model is sensitive to economic downturns.

Elevated Short-Term Volatility: 3Y volatility (94.6%) is noticeably higher than the 5Y average (77.9%).

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (77.9% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -78.3% in the extended horizon.